✦ LIBER ✦

Oral Valganciclovir Is Noninferior to Intravenous Ganciclovir for the Treatment of Cytomegalovirus Disease in Solid Organ Transplant Recipients

✍ Scribed by A. Åsberg; A. Humar; H. Rollag; A. G. Jardine; H. Mouas; M. D. Pescovitz; D. Sgarabotto; M. Tuncer; I. L. Noronha; A. Hartmann; on behalf of the VICTOR Study Group

Book ID: 114804466
Publisher: John Wiley and Sons
Year: 2007
Tongue: English
Weight: 144 KB
Volume: 7
Category: Article
ISSN: 1600-6135
DOI: 10.1111/j.1600-6143.2007.01910.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and Safety of Valganciclovir vs

Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

✍ Carlos Paya; Atul Humar; Ed Dominguez; Kenneth Washburn; Emily Blumberg; Barbara 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

Treatment of Cytomegalovirus Infection o

Treatment of Cytomegalovirus Infection or Disease in Solid Organ Transplant Recipients with Valganciclovir

✍ Jacques Fellay; Jean-Pierre Venetz; Manuel Pascual; John-David Aubert; Charles S 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB

Treatment of Cytomegalovirus Infection o

Treatment of Cytomegalovirus Infection or Disease in Solid Organ Transplant Recipients With Valganciclovir

✍ J. Fellay; J.-P. Venetz; J.-D. Aubert; C. Seydoux; M. Pascual; P.R.A. Meylan 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Long-Term Outcomes of CMV Disease Treatm

Long-Term Outcomes of CMV Disease Treatment with Valganciclovir Versus IV Ganciclovir in Solid Organ Transplant Recipients

✍ A. Åsberg; A. Humar; A. G. Jardine; H. Rollag; M. D. Pescovitz; H. Mouas; A. Big 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 194 KB

Editorial: Oral Ganciclovir Usage for Cy

Editorial: Oral Ganciclovir Usage for Cytomegalovirus Prophylaxis in Organ Transplant Recipients: Is Emergence of Resistance Imminent?

✍ Nina Singh; Victor L. Yu 📂 Article 📅 1998 🏛 Springer US 🌐 English ⚖ 74 KB

Preemptive Therapy With Intravenous Ganc

Preemptive Therapy With Intravenous Ganciclovir for the Prevention of Cytomegalovirus Disease in Lung Transplant Recipients

✍ V. Monforte; A. Román; J. Gavaldà; C. Bravo; P. Gispert; A. Pahissa; F. Morell 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 72 KB